tiprankstipranks
Trending News
More News >
Ercros SA (GB:0M0E)
LSE:0M0E

Ercros SA (0M0E) Price & Analysis

Compare
1 Followers

0M0E Stock Chart & Stats

€3.43
€0.00(0.00%)
At close: 4:00 PM EST
€3.43
€0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Diversified End-marketsErcros sells chlorine/caustic and active pharmaceutical ingredients across varied industries. This product and end-market diversity supports revenue resilience over cycles, allowing the company to shift focus between industrial and pharma demand and reduce single-market dependence.
Proven Cash GenerationPositive operating and free cash flow in 2025 shows the business can convert operations into liquidity, supporting capex, working capital and deleveraging. While cash flow has been volatile, demonstrated periodic strong conversion is a durable support for financial flexibility.
Balance Sheet Not Extremely LeveragedAlthough leverage increased, having debt still below equity provides a measurable cushion vs highly leveraged peers. That capital structure headroom supports refinancing and operational stability, helping absorb further cyclical stress without immediate solvency risk.
Bears Say
Deteriorating ProfitabilityA sustained swing into losses erodes retained earnings, restricts reinvestment and weakens competitiveness. Persistent negative operating profit reduces ability to fund R&D, maintenance and strategic initiatives, making recovery more difficult and increasing reliance on external financing.
Revenue DeclineA multiyear revenue downtrend signals structural demand, pricing or market-share challenges. Falling top-line undermines fixed-cost absorption and scale advantages, pressuring margins and cash flow consistency and making margin recovery contingent on reversing the underlying revenue weakness.
Weakened Balance Sheet TrendRising leverage alongside declining equity reduces financial flexibility and increases vulnerability to shocks. Even if absolute debt is below equity, the negative trajectory raises refinancing, covenant and cost-of-capital risks, constraining strategic investments over the medium term.

Ercros SA News

0M0E FAQ

What was Ercros SA’s price range in the past 12 months?
Ercros SA lowest share price was €2.24 and its highest was €3.47 in the past 12 months.
    What is Ercros SA’s market cap?
    Ercros SA’s market cap is €283.91M.
      When is Ercros SA’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Ercros SA’s earnings last quarter?
      Currently, no data Available
      Is Ercros SA overvalued?
      According to Wall Street analysts Ercros SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Ercros SA pay dividends?
        Ercros SA does not currently pay dividends.
        What is Ercros SA’s EPS estimate?
        Ercros SA’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Ercros SA have?
        Ercros SA has 91,436,195 shares outstanding.
          What happened to Ercros SA’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Ercros SA?
          Currently, no hedge funds are holding shares in GB:0M0E
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Ercros SA

            Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

            Ercros SA (0M0E) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Acerinox

            Options Prices

            Currently, No data available
            ---
            Popular Stocks